New $5 million competition announced for developing rapid COVID-19 testing


Xprize has unveiled a new $5 million competition to encourage the development of rapid COVID-19 testing.
The non-profit organization on Tuesday announced the Xprize Rapid COVID Testing competition to "accelerate the development of high-quality COVID-19 testing that is low cost, easy to use, and fast-turnaround, enabling frequent testing." Xprize and OpenCovidScreen are asking the "world's brightest, most innovative minds" to get involved and develop new fast and affordable testing solutions that might help facilitate a safe return to school and work amid the pandemic, as other COVID-19 testing methods can take days to produce a result.
The submissions, Xprize says, can be in one of four categories including at-home and point-of-care testing, and entries will be judged on factors like innovation, performance, turnaround time, and cost. Five teams will ultimately be awarded $1 million each, and the maximum turnaround time is 12 hours, TechCrunch reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Fast, affordable, and accessible testing is crucial to containing the COVID-19 pandemic and safely reopening schools, businesses and other vital institutions around the world,” Xprize CEO Anousheh Ansari said in a statement. "Xprize Rapid COVID Testing is inspiring the best entrepreneurial and scientific teams to come together to work towards rapid, affordable COVID-19 testing at scale, and ultimately, getting the world up and running again."
Xprize is asking teams to register for the competition by the end of August.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
How did the Wagner Group recruit young British men for arson attack?
Today's Big Question Russian operatives have been using encrypted messaging apps to groom saboteurs across Europe
-
The best graphic novels
The Week Recommends These inventive illustrated books will transport you to another world
-
How a UK wealth tax could work
A levy could be on the agenda as Rachel Reeves attempts to get the nation's finances back on track
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths